University of California girds to combat cancer, a closer look at CAR-T cell therapy, and medical tourism to China—a wave of the future?

With new drug approvals and expanded indications for new myeloma drugs at an all-time high, there is a sense of optimism in the myeloma community. Yet, even as patients experience longer survival, myeloma remains very sneaky. The disease can evolve into resistant relapse phases, demanding new therapy.

China 2013: IMF Holds Meetings in Guangzhou, China

Guangzhou, China -- You may not have heard of Guangzhou, but it is a huge city in southeast China, two hours by car or rail north of Hong Kong--a bustling manufacturing and financial hub with a population of 13 million. The Pearl River Delta mega-city area, which includes Guangzhou, has a population of approximately 40 million, and encompasses Shenzhen (home of iPad production), Dongguan, Foshan, Jiangmen and Zhongshan.

Shanghai Revisited: An Environment of Hope

A return visit to Asia by the IMF team of me, Susie Novis and Senior Global Analyst Dan Navid this past week was an exhilarating blur of activities that instructed, impressed and touched us deeply. 

China: the new frontier in the search for a cure for myeloma

I have just returned from the IMF's visit in China where there are more myeloma patients than anywhere else in the world. It is with this in mind that the IMF has established the Asian Myeloma Network, to address the growing incidence in one of the world's most densely populated regions.